Literature DB >> 12668501

Mouse model for hereditary hemorrhagic telangiectasia has a generalized vascular abnormality.

Evelyn Torsney1, Richard Charlton, Austin G Diamond, John Burn, James V Soames, Helen M Arthur.   

Abstract

BACKGROUND: Mutations in endoglin or activin like kinase-1, both involved in the endothelial transforming growth factor-beta signaling pathway, cause the autosomal dominant bleeding disorder hereditary hemorrhagic telangiectasia. We and others have reported mouse models for this disease that share the characteristic phenotype of dilated vessels and sporadic hemorrhage. The reasons for the variable phenotype in hereditary hemorrhagic telangiectasia are not understood. METHODS AND
RESULTS: After a detailed immunohistochemical analysis of 129/Ola mice, which are heterozygous for a targeted deletion in the endoglin gene, we observed intrinsic abnormalities in the vascular walls throughout the cutaneous vasculature. Postcapillary venules were dilated, and up to 70% of the vascular wall had no smooth muscle cells. The supporting layers of collagens and elastin were irregular, with thin areas, adding to the fragility of these vessels. A variable hemorrhagic phenotype was observed in which local bleeding is associated not only with fragile vessels but also with regions of inflammation.
CONCLUSIONS: These findings have relevance to our understanding of the molecular basis of vascular integrity in a wide range of diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12668501     DOI: 10.1161/01.CIR.0000058170.92267.00

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  41 in total

Review 1.  Molecular, Cellular, and Genetic Determinants of Sporadic Brain Arteriovenous Malformations.

Authors:  Brian P Walcott; Ethan A Winkler; Guy A Rouleau; Michael T Lawton
Journal:  Neurosurgery       Date:  2016-08       Impact factor: 4.654

Review 2.  Bone Morphogenetic Protein functions as a context-dependent angiogenic cue in vertebrates.

Authors:  David M Wiley; Suk-Won Jin
Journal:  Semin Cell Dev Biol       Date:  2011-10-12       Impact factor: 7.727

Review 3.  Developmental angiogenesis of the central nervous system.

Authors:  Michael R Mancuso; Frank Kuhnert; Calvin J Kuo
Journal:  Lymphat Res Biol       Date:  2008       Impact factor: 2.589

Review 4.  Diversity is in my veins: role of bone morphogenetic protein signaling during venous morphogenesis in zebrafish illustrates the heterogeneity within endothelial cells.

Authors:  Jun-Dae Kim; Heon-Woo Lee; Suk-Won Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-07-24       Impact factor: 8.311

Review 5.  The pathobiology of vascular malformations: insights from human and model organism genetics.

Authors:  Sarah E Wetzel-Strong; Matthew R Detter; Douglas A Marchuk
Journal:  J Pathol       Date:  2016-12-04       Impact factor: 7.996

6.  Brain arteriovenous malformation pathogenesis: a response-to-injury paradigm.

Authors:  Helen Kim; Hua Su; Shantel Weinsheimer; Ludmila Pawlikowska; William L Young
Journal:  Acta Neurochir Suppl       Date:  2011

7.  Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia.

Authors:  Franck Lebrin; Samly Srun; Karine Raymond; Sabrina Martin; Stieneke van den Brink; Catarina Freitas; Christiane Bréant; Thomas Mathivet; Bruno Larrivée; Jean-Léon Thomas; Helen M Arthur; Cornelis J J Westermann; Frans Disch; Johannes J Mager; Repke J Snijder; Anne Eichmann; Christine L Mummery
Journal:  Nat Med       Date:  2010-04-04       Impact factor: 53.440

8.  Endoglin promotes endothelial cell proliferation and TGF-beta/ALK1 signal transduction.

Authors:  Franck Lebrin; Marie-José Goumans; Leon Jonker; Rita L C Carvalho; Gudrun Valdimarsdottir; Midory Thorikay; Christine Mummery; Helen M Arthur; Peter ten Dijke
Journal:  EMBO J       Date:  2004-09-23       Impact factor: 11.598

Review 9.  Biology of vascular malformations of the brain.

Authors:  Gabrielle G Leblanc; Eugene Golanov; Issam A Awad; William L Young
Journal:  Stroke       Date:  2009-10-15       Impact factor: 7.914

10.  Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.

Authors:  Sara I Cunha; Evangelia Pardali; Midory Thorikay; Charlotte Anderberg; Lukas Hawinkels; Marie-José Goumans; Jasbir Seehra; Carl-Henrik Heldin; Peter ten Dijke; Kristian Pietras
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.